Cephalalgia

Papers
(The H4-Index of Cephalalgia is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care109
Harassment in the headache field: a global web-based cross-sectional survey87
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world81
High perceived isolation and reduced social support affect headache impact levels in migraine after the Covid-19 outbreak: A cross sectional survey on chronic and episodic patients80
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll68
International Classification of Headache Disorders-4 – Work in Progress 162
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials59
Evidence-based guidelines for the pharmacological treatment of migraine59
Depression screening in migraine - A double-edged sword54
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria54
Assessing migraine therapeutics51
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization49
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”44
Call for papers42
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex40
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review39
Systemic lupus erythematosus mimicking retinal migraine: a case report39
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study36
Effect of Altmetric score on manuscript citations: A randomized-controlled trial35
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study35
CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis32
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa31
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury30
An altered reward system characterizes chronic migraine with medication overuse headache30
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system28
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies28
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria28
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment28
0.066738128662109